Bio-Rad Laboratories Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Bio-Rad Laboratories Inc (BIO). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Clinical Diagnostics [Member] | $1.31B 51.3% | $1.52B 51.9% · +16.1% | $1.45B 51.8% · -4.3% | $1.49B 55.8% · +2.6% | $1.54B 59.9% · +3.3% | $1.56B 60.5% · +1.6% |
| Life Science [Member] | $1.23B 48.4% | $1.40B 47.9% · +13.7% | $1.35B 48.1% · -3.8% | $1.18B 44.1% · -12.5% | $1.03B 40.1% · -12.8% | $1.02B 39.5% · -0.7% |
| All Other Segments [Member] | $8.6M 0.3% | $5.8M 0.2% · -32.6% | $4.0M 0.1% · -31.0% | $3.5M 0.1% · -12.5% | $500.0K 0.0% · -85.7% | $0 0.0% · -100.0% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Clinical Diagnostics [Member] | $138.3M 10.6% | $181.8M 12.0% | – | – | – | – |
| Life Science [Member] | $282.6M 22.9% | $319.7M 22.8% | – | – | – | – |
| All Other Segments [Member] | $400.0K 4.7% | -$1.2M -20.7% | – | – | – | – |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| UNITED STATES | $1.00B 39.5% | $1.13B 38.7% · +12.5% | $1.16B 41.2% · +2.2% | $1.12B 42.0% · -2.9% | $1.04B 40.6% · -7.2% | $1.02B 39.6% · -1.8% |
| Europe [Member] | $857.7M 33.7% | $946.9M 32.4% · +10.4% | $851.9M 30.4% · -10.0% | $819.8M 30.7% · -3.8% | $834.1M 32.5% · +1.7% | $881.8M 34.1% · +5.7% |
| Asia [Member] | $546.5M 21.5% | $688.4M 23.6% · +26.0% | $639.4M 22.8% · -7.1% | $563.0M 21.1% · -11.9% | $521.6M 20.3% · -7.4% | $513.3M 19.9% · -1.6% |
| Other (primarily Canada and Latin America) [Member] | $136.6M 5.4% | $156.6M 5.4% · +14.6% | $155.4M 5.5% · -0.8% | $166.5M 6.2% · +7.1% | $169.3M 6.6% · +1.7% | $165.4M 6.4% · -2.3% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.